Journal
JOURNAL OF MOLECULAR DIAGNOSTICS
Volume 12, Issue 4, Pages 505-511Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/jmoldx.2010.090229
Keywords
-
Categories
Funding
- Associated Regional and University Pathologists (ARUP)
- Celebra
Ask authors/readers for more resources
Population screening has been proposed for Fragile X syndrome to identify premutation carrier females and affected newborns. We developed a PCR-based assay capable of quickly detecting the presence or absence of an expanded FMR1 allele with high sensitivity and specificity. This assay combines a triplet repeat primed PCR with high-throughput automated capillary electrophoresis. We evaluated assay performance using archived samples sent for Fragile X diagnostic testing representing a range of Fragile X CGG-repeat expansions. Two hundred five previously genotyped samples were tested with the new assay. Data were analyzed for the presence of a trinucleotide ladder extending beyond 55 repeats, which was set as a cut-off to identify, expanded FMR1 alleles. We identified expanded FMR1 alleles in 132 samples (59 premutation, 71 full mutation, 2 mosaics) and normal FMR1 alleles in 73 samples. We found 100% concordance with previous results from PCR and Southern blot analyses. In addition, we show feasibility of using this assay with DNA extracted from dried-blood spots. Using a single PCR combined with high-throughput fragment analysis on the automated capillary electrophoresis instrument, we developed a rapid and reproducible PCR-based laboratory assay that meets many of the requirements for a first-tier test for population screening. (J Mol Diagn 2010, 12:505-511; DOI: 10.2353/jmoldx.2010.090229)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available